Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Wald ratio,1,1.94 [0.99-3.82],0.0544632863726464,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_IHD,Wald ratio,1,0.86 [0.7-1.04],0.122815607209499,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,0.73 [0.48-1.13],0.155476287680166,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_CORATHER,Wald ratio,1,0.86 [0.69-1.08],0.185307164102289,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_CHD,Wald ratio,1,0.87 [0.69-1.09],0.226457464492449,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Wald ratio,1,0.47 [0.13-1.64],0.235326597147436,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Wald ratio,1,1.2 [0.88-1.65],0.256777769690231,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Wald ratio,1,0.5 [0.14-1.75],0.277192845326242,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Wald ratio,1,0.9 [0.71-1.12],0.336043334871889,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_ANGINA,Wald ratio,1,0.9 [0.7-1.16],0.421227522340447,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Wald ratio,1,1.11 [0.85-1.45],0.42482515051035,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Wald ratio,1,1.07 [0.91-1.25],0.433016846366272,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,1.08 [0.87-1.34],0.465416766380592,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Wald ratio,1,1.06 [0.9-1.26],0.478425460264131,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Wald ratio,1,1.07 [0.87-1.32],0.500940635110164,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Wald ratio,1,1.09 [0.84-1.41],0.51364252039566,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,KRA_PSY_MOOD_EXMORE,Wald ratio,1,0.92 [0.7-1.21],0.543696913249034,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,K11_GIDISEASES,Wald ratio,1,1.04 [0.91-1.2],0.564802332374172,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,1.05 [0.85-1.29],0.660407561888421,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Wald ratio,1,0.83 [0.35-1.95],0.661677234661201,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Wald ratio,1,0.96 [0.79-1.16],0.668127846806229,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_PAD,Wald ratio,1,0.89 [0.52-1.53],0.669804828920885,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Wald ratio,1,1.05 [0.85-1.29],0.671288578960312,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Wald ratio,1,1.03 [0.89-1.2],0.687110359002102,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_BACT_IMPL,Wald ratio,1,1.07 [0.75-1.53],0.70136640265349,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Wald ratio,1,0.92 [0.62-1.38],0.702534292202772,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Wald ratio,1,0.93 [0.55-1.57],0.785812632798609,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,1.02 [0.82-1.26],0.892464737192739,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Wald ratio,1,1.01 [0.86-1.19],0.905668131677703,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Wald ratio,1,1.01 [0.75-1.36],0.960626599670133,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,1 [0.78-1.29],0.999339451093201,cis
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,6,0.68 [0.58-0.81],7.61031247321863e-06,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,6,0.75 [0.63-0.89],0.00126900229459186,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,6,0.83 [0.72-0.95],0.00683036552082019,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,6,0.87 [0.72-1.04],0.114826742471748,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,6,0.88 [0.75-1.03],0.118148373247557,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,6,1.1 [0.97-1.24],0.135588381518554,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,6,1.09 [0.97-1.22],0.150485228943088,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,6,0.68 [0.39-1.18],0.172178034520022,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,6,1.08 [0.96-1.21],0.22408396021519,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,6,0.89 [0.73-1.08],0.247034563172272,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,6,0.92 [0.8-1.06],0.251252800843252,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,6,1.18 [0.88-1.58],0.278654471294318,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,6,0.91 [0.77-1.08],0.28479805904962,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,6,0.92 [0.78-1.09],0.345785901447959,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,6,0.71 [0.33-1.49],0.360397819244612,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,6,1.04 [0.93-1.17],0.477798957799614,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,6,0.84 [0.41-1.71],0.631758902876465,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,6,0.92 [0.63-1.36],0.679257157808922,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,6,0.97 [0.68-1.36],0.842099842550827,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,6,0.98 [0.77-1.24],0.84926758924463,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,6,1.01 [0.92-1.1],0.886499921090971,trans
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,6,1 [0.9-1.1],0.976338567545708,trans
